Literature DB >> 12918601

Role of the psychiatrist in the care of patients with hepatitis C and HIV/AIDS.

Stephen Price1, Juanita Goyette.   

Abstract

Hepatitis C and HIV/AIDS are among the most significant infectious diseases of our time. Psychiatric patients are often part of the higher risk population to contract these diseases, and patients who have contracted these diseases experience a wide variety of psychiatric problems associated with the underlying infection and with its treatment. The authors provide an overview of these infectious diseases and then describe the varying roles psychiatrists have in caring for these patients in the various settings of their work. The complexity of these patients presents a unique challenge to, and opportunity for, psychiatrists to integrate and coordinate their interventions with those of other medical providers and thereby enhance the patient's cooperation with all aspects of care.

Entities:  

Mesh:

Year:  2003        PMID: 12918601     DOI: 10.1023/a:1024118605428

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  24 in total

Review 1.  Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review.

Authors:  E Dieperink; M Willenbring; S B Ho
Journal:  Am J Psychiatry       Date:  2000-06       Impact factor: 18.112

Review 2.  Neuropsychiatric toxicity of antiviral treatment in chronic hepatitis C.

Authors:  R J Fontana
Journal:  Dig Dis       Date:  2000       Impact factor: 2.404

3.  Adding low-dose antidepressants to interferon alpha treatment for chronic hepatitis C improved psychiatric tolerability in a patient with schizoaffective psychosis.

Authors:  M Schäfer; F Schmidt; B Amann; S Schlösser; K Loeschke; H Grunze
Journal:  Neuropsychobiology       Date:  2000       Impact factor: 2.328

Review 4.  Medical illness in patients with schizophrenia.

Authors:  L S Goldman
Journal:  J Clin Psychiatry       Date:  1999       Impact factor: 4.384

5.  Psychiatric comorbidity among hepatitis C-positive patients.

Authors:  S P Yovtcheva; M A Rifai; J K Moles; B J Van der Linden
Journal:  Psychosomatics       Date:  2001 Sep-Oct       Impact factor: 2.386

6.  Timing of psychiatric consultations: the impact of social vulnerability and level of psychiatric dysfunction.

Authors:  P de Jonge; F J Huyse; G M Ruinemans; F C Stiefel; J S Lyons; J P Slaets
Journal:  Psychosomatics       Date:  2000 Nov-Dec       Impact factor: 2.386

7.  Risk factors for HIV/AIDS and hepatitis C among the chronic mentally ill.

Authors:  S Davidson; F Judd; D Jolley; B Hocking; S Thompson; B Hyland
Journal:  Aust N Z J Psychiatry       Date:  2001-04       Impact factor: 5.744

8.  Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland.

Authors:  Danielle C Ompad; Crystal M Fuller; David Vlahov; David Thomas; Steffanie A Strathdee
Journal:  Clin Infect Dis       Date:  2002-09-03       Impact factor: 9.079

9.  Depression, fatigue, and functional disability in patients with chronic hepatitis C.

Authors:  M M Dwight; K V Kowdley; J E Russo; P S Ciechanowski; A M Larson; W J Katon
Journal:  J Psychosom Res       Date:  2000-11       Impact factor: 3.006

10.  Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

Authors:  J G McHutchison; S C Gordon; E R Schiff; M L Shiffman; W M Lee; V K Rustgi; Z D Goodman; M H Ling; S Cort; J K Albrecht
Journal:  N Engl J Med       Date:  1998-11-19       Impact factor: 91.245

View more
  1 in total

Review 1.  Methodological approaches in the assessment of interferon-alfa-induced depression in patients with chronic hepatitis C - a critical review.

Authors:  Arne Schäfer; Hans-Ulrich Wittchen; Jochen Seufert; Michael R Kraus
Journal:  Int J Methods Psychiatr Res       Date:  2007       Impact factor: 4.035

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.